Concentration effect modelling with converting enzyme inhibitors in man [letter]
Open Access
- 1 April 1983
- journal article
- Published by Wiley
- Vol. 15 (4) , 506-507
- https://doi.org/10.1111/j.1365-2125.1983.tb01542.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.British Journal of Clinical Pharmacology, 1982
- Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.British Journal of Clinical Pharmacology, 1982
- Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.British Journal of Clinical Pharmacology, 1982
- Opposite Effects of Captopril on Angiotensin I-Converting Enzyme ‘Activity’ and ‘Concentration’; Relation between Enzyme Inhibition and Long-Term Blood Pressure ResponseClinical Science, 1981
- The Measurement of Angiotensin-Converting Enzyme in Subjects Receiving CaptoprilNew England Journal of Medicine, 1980
- Disposition of captopril in normal subjectsClinical Pharmacology & Therapeutics, 1980
- Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.Hypertension, 1980